Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Landmark Bio PBLLC

Formerly known as the new center for advanced biological innovation and manufacturing (or “CABIM”), Landmark Bio, PBLLC is a public benefit limited liability company that was formed to advance the development of transformative new medicines by translating today’s cutting-edge research into tomorrow’s breakthrough therapies. The cross-sector partnership harnesses world-leading expertise to accelerate fast-emerging and promising science, the challenges of which are daunting for any single institution to tackle alone. Board members include leaders from Harvard University, Massachusetts Institute of Technology (MIT), FUJIFILM Diosynth Biotechnologies (FDB), Cytiva, and Alexandria Real Estate Equities, Inc. Other collaborating institutions include Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, the Dana-Farber Cancer Institute, Massachusetts General Hospital, and the Massachusetts Life Sciences Center. *

 

Period Start 2021-07-29 start jv
Products Industry contract manufacturing (biologicals)
  Industry 2 cell and gene therapy manufacturing (CGT manufacturing)
Persons Person Zheng, Ran (Landmark Bio 202107– CEO before Orchard Therapeutics + Amgen + Diosynth + Genzyme)
  Person 2 Ligner, Emmanuel (General Electric 201812 President + CEO GE Healthcare Life Sciences)
     
Region Region Watertown, MA
  Country United States (USA)
  Street 300 North Beacon Street
  City 02472 Watertown, MA
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Landmark Bio PPLLC. (7/29/21). "Press Release: Introducing Landmark Bio and Appointment of Ran Zheng as CEO". Watertown, MA.
     
   
Record changed: 2023-07-10

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Landmark Bio PBLLC


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top